Pharmacogenetic markers to predict safety of antipsychotics in adolescents experiencing acute psychotic episodes
Introduction There are relatively fewer pharmacogenetic studies of antipsychotics in adolescents than in adult patients. The development of personalized pharmacotherapy is promising. Objectives Identify the most significant pharmacogenetic predictors of antipsychotic safety in adolescents experie...
Main Authors: | D. Ivashchenko, K. Akmalova, E. Grishina, Y. Shevchenko, D. Sychev |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-06-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S092493382200219X/type/journal_article |
Similar Items
-
Pharmacogenetics biomarkers of antipsychotics’ safety in adolescents with acute psychotic episode
by: D. V. Ivashchenko, et al.
Published: (2019-12-01) -
The polymorphic variants DRD2 rs1800497 and ABCB1 3435C>T are associated with antipsychotic safety parameters in adolescents with an acute psychotic episode: the results of a pilot study
by: D. V. Ivashchenko, et al.
Published: (2020-10-01) -
Off-label antipsychotics prescription to adolescents with acute psychotic episodes does not cause adverse drug reactions
by: D. V. Ivashchenko, et al.
Published: (2021-06-01) -
Efficacy and safety of antipsychotics in adolescents with an acute psychotic episode in relation to the activity of CYP3A and CYP2D6 isoenzymes
by: D. V. Ivashchenko, et al.
Published: (2020-12-01) -
Pharmacogenetic markers of antipsychotic-induced weight gain: leptin and neuroepeptide Y
by: V. S. Dobrodeeva, et al.
Published: (2021-04-01)